mRNA-1444
Phase 1RNA therapy
ModernamRNA-1444 is one of 3 therapeutic programs targeting Mpox. It is currently in Phase 1.
1
Indications
0
Total Trials
0
Active Trials
2
Competitors
Pipeline
Status by Indication[1]
Competition
Competitive Landscape
3 competitors in Mpox
#DrugCompanyPhaseTrials
1Tpoxx
SSIGA Technologies
Approved
Bnt166a
BioNTechPhase 2
mRNA-1444
ModernaPhase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Sources
References
- [1]Open Targets Platform — Drug–disease associations for mRNA-1444. EMBL-EBI & Wellcome Sanger Institute.
- [2]
Details
Drug Info
Quick Facts
- Modality
- RNA therapy
- Highest Phase
- Phase 1
- Company